EVOQUE
7Pages

Catalog excerpts

A treatment option being studied for tricuspid regurgitation Talk to your doctor or a research coordinator to find out if this clinical trial is right for you

Open the catalog to page 1

What is tricuspid regurgitation? If you or a loved one has tricuspid regurgitation (TR), know that you’re not alone and that you have options when it comes to treatment. But first, let’s understand what TR is. Tricuspid regurgitation can impact your quality of life and can also lead to heart failure, which can lead to death. In spite of the serious risks, there are very few treatment options for patients like you who are living with TR. Tricuspid regurgitation occurs when the tricuspid valve on the right side of the heart doesn’t close all the way, usually because the valve has been...

Open the catalog to page 2

What are my TR treatment options? There are a few different ways to treat TR Edwards EVOQUE tricuspid valve replacement system Medication Treats the root cause of TR Less invasive Transcatheter tricuspid valve repair or replacement Medications are used to control symptoms. Treatment for TR depends on the underlying cause and severity of the disease. Open heart surgery Surgery on the tricuspid valve is occasionally done when there is some other surgery being planned on your heart. A thin tube would be placed through a vein in your leg to reach your heart and either repair or replace the...

Open the catalog to page 3

What is the TRISCEND II clinical trial? This trial is studying the treatment of TR with the EVOQUE transcatheter valve replacement system • This trial will examine an innovative tricuspid valve replacement system using a transcatheter procedure (no open heart surgery) • During this clinical trial, you will either be treated with medication alone, or you will get a valve replacement using the EVOQUE system in addition to being treated with medication • Your health will be monitored throughout the clinical trial and after the valve replacement. This will require you to come in for several...

Open the catalog to page 4

Interested in joining the TRISCEND II clinical trial? You may be eligible for this trial if you’re an adult and you have severe or greater, symptomatic tricuspid regurgitation, as determined by your heart team. Ask your doctor or research coordinator for the full list of criteria. If you choose to participate, you will be asked to complete health and imaging assessments to ensure you meet the criteria to continue in the clinical trial. Problems with the tricuspid valve often go untreated, but this study may unveil critical information about a new solution. Your participation may assist in...

Open the catalog to page 5

Ask your doctor for more information about the clinical trial Write down any additional questions to ask your doctor in the space provided Notes: D o you think transcatheter tricuspid valve replacement is an option for me? What testing will I have to do during the trial? Will I be able to take the medications I take now? What are the risks of participating?

Open the catalog to page 6

Talk to your doctor to determine if you are eligible to participate in this clinical trial Place your healthcare professional’s business card here or fill in their contact information Name: Phone: Email: CAUTION – Investigational device. Limited by Federal (United States) law to investigational use. Edwards Lifesciences is the Sponsor of the TRISCEND II Pivotal Trial. Edwards, Edwards Lifesciences, the stylized E logo, EVOQUE, TRISCEND, and TRISCEND logo are trademarks or service marks of Edwards Lifesciences Corporation or its affiliates. All other trademarks or service marks are the...

Open the catalog to page 7

EVOQUE 7Pages

Catalog excerpts

All Edwards Lifesciences catalogs and technical brochures

EVOQUE
7Pages